Zhuhai Rundu Pharmaceutical Co., Ltd. (002923.SZ)
CNY 10.32
(-0.96%)
CNY 10.32
(-0.96%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.29 Billion | 1.37 Billion | 1.18 Billion | 1.25 Billion | 1.35 Billion | 1.04 Billion |
| Cost of Revenue | 685.02 Million | 600.78 Million | 458.83 Million | 460.88 Million | 379.96 Million | 260.26 Million |
| Gross Profit | 606.85 Million | 771.44 Million | 731.09 Million | 791.74 Million | 979.94 Million | 783.59 Million |
| Operating Expenses | 511.28 Million | 553.03 Million | 571.3 Million | 632.26 Million | 850.38 Million | 674.31 Million |
| Selling, General and Administrative Expenses | 345 Million | 413.15 Million | 431.89 Million | 493.28 Million | 712.56 Million | 589.06 Million |
| Research and Development Expenses | 129.44 Million | 95.59 Million | 92.13 Million | 102.46 Million | 114.54 Million | 66.02 Million |
| Other Expenses | - | 44.29 Million | 47.27 Million | 36.5 Million | 23.28 Million | -125.78 Thousand |
| Cost and Expenses | 1.2 Billion | 1.15 Billion | 1.03 Billion | 1.09 Billion | 1.23 Billion | 934.57 Million |
| Operating Income | 86.26 Million | 181.35 Million | 153.78 Million | 153.58 Million | 133.55 Million | 119.84 Million |
| Interest Expense | 17.23 Million | 6.96 Million | 1.77 Million | 1.77 Million | 1.99 Million | 3.09 Million |
| Income Tax Expense | 19.14 Million | 25.46 Million | 11.97 Million | 12.96 Million | 13.54 Million | 12.87 Million |
| Earnings before Tax | 86.03 Million | 180.93 Million | 151.73 Million | 148.83 Million | 132.44 Million | 119.71 Million |
| Net Income | 66.89 Million | 155.47 Million | 139.76 Million | 135.86 Million | 118.89 Million | 106.84 Million |
| Earnings Per Share Basic | 0.20 | 0.46 | 0.42 | 0.41 | 0.36 | 0.33 |
| Earnings Per Share Diluted | 0.20 | 0.46 | 0.42 | 0.41 | 0.36 | 0.32 |
| Weighted Average Shares Outstanding | 334.49 Million | 334.87 Million | 334.7 Million | 334.14 Million | 330.88 Million | 327.59 Million |
| Weighted Average Shares Outstanding (Diluted) | 334.49 Million | 334.87 Million | 334.7 Million | 334.14 Million | 330.88 Million | 329.58 Million |
| Gross Margin | 0.47 | 0.56 | 0.61 | 0.63 | 0.72 | 0.75 |
| EBIT Margin | 0.17 | 0.21 | 0.19 | 0.16 | 0.13 | 0.15 |
| Profit Margin | 0.05 | 0.11 | 0.12 | 0.11 | 0.09 | 0.10 |
| EBITDA | 215.02 Million | 266.43 Million | 227.02 Million | 200.57 Million | 182.03 Million | 151.81 Million |
| Earnings Before Tax Margin | 0.07 | 0.13 | 0.13 | 0.12 | 0.10 | 0.11 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 277.34 Million | 291.07 Million | 306.09 Million | 346.52 Million | 1.29 Billion | 289.92 Million |
| Cost of Revenue | 163.7 Million | 152.67 Million | 153.97 Million | 174.51 Million | 638.76 Million | 148.1 Million |
| Gross Profit | 113.63 Million | 138.39 Million | 152.12 Million | 172 Million | 653.12 Million | 141.82 Million |
| Operating Expenses | 119.12 Million | 114.01 Million | 112.97 Million | 126.55 Million | 511.28 Million | 143.54 Million |
| Selling, General and Administrative Expenses | 80.57 Million | 56.73 Million | 88.49 Million | 28.76 Million | - | 132.47 Million |
| Research and Development Expenses | 37.77 Million | 34.87 Million | 24.95 Million | 51.64 Million | - | 34.41 Million |
| Other Expenses | -772.72 Thousand | -45.71 Thousand | -200.1 Thousand | -365.77 Thousand | -226.81 Thousand | -286.79 Thousand |
| Cost and Expenses | 282.82 Million | 266.68 Million | 266.94 Million | 301.07 Million | 1.15 Billion | 291.64 Million |
| Operating Income | -5.48 Million | 10.83 Million | 33.72 Million | 7.12 Million | 86.26 Million | -4.71 Million |
| Interest Expense | 3.82 Million | 4.58 Million | 3.48 Million | 3.95 Million | 16.11 Million | 4.02 Million |
| Income Tax Expense | -2.63 Million | 2.04 Million | 4.47 Million | 5.41 Million | 19.14 Million | -1.3 Million |
| Earnings before Tax | -3.25 Million | 10.78 Million | 33.52 Million | 6.75 Million | 86.03 Million | -5 Million |
| Net Income | -620.95 Thousand | 8.74 Million | 29.05 Million | 1.34 Million | 66.89 Million | -3.69 Million |
| Earnings Per Share Basic | -0.00 | 0.09 | 0.09 | 0.00 | - | -0.01 |
| Earnings Per Share Diluted | -0.00 | 0.09 | 0.09 | 0.00 | - | -0.01 |
| Weighted Average Shares Outstanding | 334.89 Million | 322.84 Million | 322.84 Million | 354.68 Million | 334.49 Million | 334.89 Million |
| Weighted Average Shares Outstanding (Diluted) | 334.89 Million | 322.84 Million | 322.84 Million | 354.6 Million | 334.49 Million | 334.89 Million |
| Gross Margin | 0.41 | 0.48 | 0.50 | 0.50 | 0.51 | 0.49 |
| EBIT Margin | 0.00 | 0.09 | 0.13 | 0.13 | - | -0.01 |
| Profit Margin | -0.00 | 0.03 | 0.09 | 0.00 | 0.05 | -0.01 |
| EBITDA | 568.09 Thousand | 25 Million | 39.96 Million | 44.65 Million | - | -1.91 Million |
| Earnings Before Tax Margin | -0.02 | 0.04 | 0.11 | 0.02 | 0.07 | -0.02 |
YAMNF
KELRF
HUD
VPRPL
INXSF
6545